The UK’s National Institute for Health and Care Excellence (NICE) has approved the use of two new non-invasive tests to aid in the diagnosis of endometriosis, a move intended to reduce the years of waiting many women currently face before receiving an accurate diagnosis.
Endometriosis affects approximately one in ten women of reproductive age. The condition occurs when tissue similar to the lining of the uterus grows outside the organ, often affecting the ovaries, fallopian tubes, and pelvic lining, and in some cases, the bladder or intestines. It causes chronic pelvic pain, severe menstrual pain, heavy bleeding, and potential fertility issues. Currently, the average time to diagnosis in the UK ranges from seven to over nine years, often due to the condition’s symptoms overlapping with other issues like irritable bowel syndrome or pelvic inflammatory disease.
New Diagnostic Technologies
The two newly approved tests, Endotest and EndoSure, offer different approaches to identifying the condition without relying solely on traditional surgical methods.
* Endotest: This test involves collecting a simple saliva sample in a doctor’s clinic. The sample is then sent to a laboratory to analyze specific micro-ribonucleic acid (microRNA) molecules that may indicate the presence of endometriosis.
* EndoSure: This diagnostic tool measures the electrical signals of the intestines using sensors attached to the abdomen. The procedure requires the patient to fast for six to eight hours before the test, followed by drinking water for 45 minutes during the examination, with results available immediately upon completion.
According to NICE, these tests are not intended to replace traditional diagnostic methods. Instead, they are designed to assist doctors in cases where clinical examinations or imaging results are normal or inconclusive, but suspicion of endometriosis remains. The tests will be used within the National Health Service (NHS) on a three-year pilot basis to gather additional data on their efficacy before a final, permanent adoption is considered.
Addressing the Diagnostic Gap
The current standard for diagnosis often involves a laparoscopy, a minimally invasive surgical procedure that requires anesthesia. While effective, the surgery is costly and often involves long waiting lists. By providing less invasive alternatives, health officials hope to reduce the need for surgical intervention, thereby alleviating pressure on hospital operating rooms and allowing surgical teams to prioritize urgent cases.
Dr. Anastasia Chalkidou, director of the health technology program at NICE, stated that these tests have the potential to provide non-invasive tools that help primary care physicians detect the disease earlier, allowing for faster treatment initiation. Dr. Jill Busby, a consultant gynecologist, described the new tests as a “paradigm shift” that could reduce the need for surgery and grant patients access to appropriate care sooner.
Context and Ongoing Research
The delay in diagnosis is a significant hurdle for patients. A survey of over 10,000 women revealed that more than half had to visit a general practitioner more than ten times before discovering the cause of their symptoms, with many eventually seeking care in emergency departments due to the intensity of their pain.
Scientific efforts to improve detection are expanding beyond these new clinical tests. Researchers at the University of Edinburgh have identified a distinct “hormonal fingerprint” associated with endometriosis, characterized by elevated levels of specific androgen hormones, particularly 11-ketotestosterone. A study published in the *European Journal of Endocrinology* found that this hormonal signature successfully identified over 95% of the women with the condition, highlighting potential avenues for future diagnostic development.
The organization Endometriosis UK has welcomed the introduction of the new tests but emphasized that their success depends on broader efforts, including the training of doctors and nurses to recognize the early symptoms of the disease. Health experts maintain that women experiencing persistent pelvic pain, severe menstrual cramps, or difficulty conceiving should not dismiss these symptoms as normal and should seek medical evaluation to improve their long-term quality of life and minimize potential complications.
Find more reporting in our Health section.
